淋巴增生性疾病的临床试验
总计144476个结果
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)完全的
-
Johnson & Johnson Pharmaceutical Research & Development...Janssen Pharmaceutica N.V., Belgium完全的
-
Assistance Publique - Hôpitaux de ParisFrench Innovative Leukemia Organisation未知
-
Maastricht University Medical CenterZonMw: The Netherlands Organisation for Health Research and Development完全的
-
WiSP Wissenschaftlicher Service Pharma GmbHLudwig-Maximilians - University of Munich; Chugai Pharma GmbH完全的霍奇金病 | 非霍奇金淋巴瘤 | 多发性骨髓瘤
-
University of NebraskaNational Cancer Institute (NCI)完全的
-
Toronto Sunnybrook Regional Cancer Centre未知
-
University of Michigan Rogel Cancer CenterAmerican Institute for Cancer Research招聘中
-
M.D. Anderson Cancer CenterSpectrum Pharmaceuticals, Inc完全的
-
Bio-Cancer Treatment International LimitedThe University of Hong Kong终止
-
Centre Hospitalier Universitaire, Amiens未知
-
University of Michigan Rogel Cancer CenterGlaxoSmithKline; Gilead Sciences撤销
-
Southwest Oncology GroupNational Cancer Institute (NCI)完全的
-
Jonsson Comprehensive Cancer CenterAmgen完全的淋巴瘤 | 白血病 | 贫血 | 未明确的成人实体瘤,特定方案 | 多发性骨髓瘤和浆细胞肿瘤 | 淋巴增生性疾病 | 癌前/非恶性疾病美国
-
Sara V. LatorreInstituto de Salud Carlos III完全的
-
Kecellitics Biotech Company LtdHebei Yanda Ludaopei Hospital未知淋巴瘤 | 白血病
-
City of Hope Medical CenterNational Cancer Institute (NCI)完全的
-
Rennes University HospitalVanderbilt University完全的
-
M.D. Anderson Cancer Center完全的
-
H. Lee Moffitt Cancer Center and Research InstituteSeagen Inc.撤销